SENSEI BIOTHERAPEUTICS INC
SENSEI BIOTHERAPEUTICS INC logo
SNSE

SENSEI BIOTHERAPEUTICS INC (SNSE)

$1.534.79%

Market is closed
– opens on 8 PM, 05 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$1.45
Day's Range
$1.53
$1.3
52-Week Range
$7.19
1 month return8.51%
3 month return20.31%
1 year return77.83%
5 year return91.9%

Company Information

Sensei Biotherapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company has developed a proprietary bacteriophage-based platform, ImmunoPhage™, that enables the rapid generation of immune activating therapeutic agents that fully engage the immune system. Using the ImmunoPhage™ platform, Sensei is developing a library of ImmunoPhage, called Phortress™, to target multiple tumor-associated antigens to create a personalized yet off-the-shelf cocktail approach for treating cancer patients. The platform enables efficient, scalable and cost-effective manufacturing to support all of Sensei’s clinical programs. The company’s most advanced immunotherapy, SNS-301, a first-in-class ImmunoPhage™ targeting the tumor antigen Aspartyl beta Hydroxylase (ASPH), is currently in a Phase 1/2 clinical trial in patients with advanced Squamous Cell Carcinoma of the Head and Neck. Earlier stage programs include SNS-401, a ImmunoPhage™ cocktail for the treatment of Merkel Cell Carcinoma, and SNS-VISTA, an antibody-based therapeutic targeting an immune checkpoint gene that inhibits anti-tumor immune responses called V-domain Ig suppressor of T cell activation (VISTA).
OrganizationSENSEI BIOTHERAPEUTICS INC
Employees44
CEOMr. John K. Celebi M.B.A., MBA
IndustryHealthcare

Analyst Recommendation

based on 3 analysts ratings

Hold
33%
Buy
66%
Hold
0%
Sell

Based on 3 Wall street analysts offering stock ratings for SENSEI BIOTHERAPEUTICS INC(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 205.23%

Current

$1.53

Target

$4.67

Recommendation Trend

Based on 3 analyst

Current1M Ago3M Ago
Buy
1
7
7
Hold
2
3
3
Sell
0
0
0
Consensus
HOLD
BUY
BUY

Highlights

Market Capitalization
44.9M
Book Value
$3.71
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-1.34
Wall Street Target Price
4.67

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
0.37
Enterprise Value
-65765999
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
1.51

Technicals

50 Day MA
1.49
200 Day MA
2.01

Institutional Holdings

RA Capital Management, LLC

2.36%

Vanguard Group Inc

1.87%

Newtyn Management LLC

1.35%

Renaissance Technologies Corp

0.8%

Millennium Management LLC

0.44%

Duquesne Family Office LLC

0.33%

Discover more

Frequently Asked Questions

What is SENSEI BIOTHERAPEUTICS INC share price today?

Can Indians buy SENSEI BIOTHERAPEUTICS INC shares?

How can I buy SENSEI BIOTHERAPEUTICS INC shares from India?

Can Fractional shares of SENSEI BIOTHERAPEUTICS INC be purchased?

What are the documents required to start investing in SENSEI BIOTHERAPEUTICS INC stocks?

What are today’s High and Low prices of SENSEI BIOTHERAPEUTICS INC?

What are today’s traded volumes of SENSEI BIOTHERAPEUTICS INC?

What is today’s market capitalisation of SENSEI BIOTHERAPEUTICS INC?

What is the 52 Week High and Low Range of SENSEI BIOTHERAPEUTICS INC?

How much percentage SENSEI BIOTHERAPEUTICS INC is down from its 52 Week High?

How much percentage SENSEI BIOTHERAPEUTICS INC is up from its 52 Week low?

What are the historical returns of SENSEI BIOTHERAPEUTICS INC?

Who is the Chief Executive Officer (CEO) of SENSEI BIOTHERAPEUTICS INC?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*